Protagonist Therapeutics PTGX
NASDAQ PTGX
$134.86 -1.40 (-1.03%)
At close: Nov 11, 2026 · 4:00 PM EST

Protagonist Therapeutics (PTGX) Current Taxes (2024 - 2026)

Updated

Protagonist Therapeutics (PTGX) posted Current Taxes of $1.89 million for Q1 2025, down 43.2% from $3.33 million a year earlier and down 29.8% from the prior quarter.

Analysis

Protagonist Therapeutics (PTGX) Current Taxes (2024 - 2026) Analysis & Trends

At the end of FY2024, Protagonist Therapeutics' Current Taxes came in at $2.69 million.

  • Quarterly Current Taxes has run from a low of $1.05 million in Q3 2024 to a high of $3.33 million in Q1 2024 over five years.
  • According to Business Quant data, Current Taxes for the three prior quarters was $2.69 million (Q4 2024), $1.05 million (Q3 2024) and $2.65 million (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.98 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.31 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.62 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 438.00 Mn
10 Protagonist Therapeutics 8.89 Bn 6.19 Bn 273.31 Mn 4.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.22 Mn
Mar 31, 2025 1.89 Mn
Dec 31, 2024 2.69 Mn
Sep 30, 2024 1.05 Mn
Jun 30, 2024 2.65 Mn
Mar 31, 2024 3.33 Mn
API Access

Protagonist Therapeutics Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=PTGX&period=max&api_key=YOUR_API_KEY